Paul R Edick Insider Trading $SCMP Sucampo Pharmaceuticals, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Paul R Edick.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Paul R Edick. Paul R Edick is Director in PDL BIOPHARMA, INC. ($PDLI) and Director in NEWLINK GENETICS CORP ($NLNK) and See Remarks in XERIS PHARMACEUTICALS INC ($XERS) and Director in Sucampo Pharmaceuticals, Inc. ($SCMP) and Director in Milestone Pharmaceuticals Inc. ($MIST) and Director in Neos Therapeutics, Inc. ($NEOS) and Director in Iterum Therapeutics plc ($ITRM).

Paul R Edick in Sucampo Pharmaceuticals, Inc.

Trading Symbol: SCMP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Paul R Edick: Director
Holdings: 14,930 shares
Current Value: $169,456
Latest Transaction: Jun 05 2017
$SCMP Market Capitalization: $496.69M
$SCMP Previous Close: $11.35

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Paul R Edick in Sucampo Pharmaceuticals, Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, ITRM, NLNK, MIST, NEOS, PDLI, SCMP, XERS

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 05 2017	SCMP	Sucampo Pharmaceut ...	Edick Paul R	Director	Option Exercise	A	10.30	10,000	103,000	10,000
Jun 05 2017	SCMP	Sucampo Pharmaceut ...	Edick Paul R	Director	Grant	A	0.00	5,130	0	14,930	9.8 K to 14.9 K (+52.35 %)
Aug 03 2016	SCMP	Sucampo Pharmaceut ...	Edick Paul R	Director	Grant	A	0.00	14,700	0	14,700	0 to 14.7 K

Page: 1